Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
STEAP3 metalloreductase | 0.666 | 0.385 | 5.3E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
STEAP3 metalloreductase | 0.666 | 0.385 | 5.3E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
STEAP3 metalloreductase | 0.666 | 0.385 | 5.3E-09 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
trimethyllysine hydroxylase, epsilon | 0.821 | 0.231 | 8.0E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
trimethyllysine hydroxylase, epsilon | 0.821 | 0.231 | 8.0E-05 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
trimethyllysine hydroxylase, epsilon | 0.821 | 0.231 | 8.0E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
trimethyllysine hydroxylase, epsilon | 0.821 | 0.231 | 8.0E-05 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
YY1 associated protein 1 | 0.711 | 0.462 | 1.9E-18 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ASXL transcriptional regulator 2 | 0.617 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
ASXL transcriptional regulator 2 | 0.617 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 |